ArticleBMC gastroenterology2026
Acute oesophageal necrosis: single centre experience.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAcute oesophageal necrosis (AEN) is a rare but important cause of upper gastrointestinal bleeding (UGIB). The prognosis is poor and related to the presence of concomitant diseases. In this study, we aimed to evaluate the outcomes of patients with AEN. MATERIALS AND
methodsPatients who were admitted to the endoscopy unit of Adana City Training and Research Hospital between January 2015 and July 2025 who were diagnosed with AEN were included in the study. Patient files, past medical records, endoscopic findings and outcomes were evaluated retrospectively.
resultsAEN was seen in 29 (0.12%) of the 24,805 endoscopies. The mean patient age was 66.2 ± 18 (24-92) years, and 15 (51.7%) patients were female. Most patients had malignancies, diabetes mellitus, hypertension, or coronary artery disease. The most common presentations were haematemesis and melena. In terms of oesophageal involvement, pan oesophageal necrosis and middle oesophageal necrosis were the most common forms of the disease. Thirteen (44.8%) patients died during hospitalization. Most mortality was caused by accompanying diseases, particularly sepsis. Only three patients died directly due to AEN.
conclusionAEN should initially be considered a cause of UGIB in elderly patients with comorbid diseases. The outcomes of patients with AEN are poor, mostly due to older age and comorbid conditions such as malignancy, diabetes mellitus, heart disease, and cirrhosis. To gain a better understanding of AEN, prospective and multicentre studies with larger patient populations are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.